BAC BV and Life Technologies launch high speed affinity HPLC columns for pharmaceutical process monitoring
BAC BV, a provider of antibody-based affinity purification technology, has teamed with Life Technologies Corporation, to launch of a range of POROS Capture Select affinity columns.
By combining BAC's CaptureSelect affinity ligand technology with Life Technologies' POROS resin, the companies now claim to offer a platform for high speed, high performance product-specific process monitoring for a broad range of biomolecules.
The POROS CaptureSelect line of analytical columns, which offer quantitation of classes of biomolecules in minutes, are the first products resulting from the companies' strategic collaboration announced in June last year.
The initial product line includes: POROS CaptureSelect LC-kappa and POROS CaptureSelect LC-lambda; for the analysis of human antibodies and antibody fragments containing either a kappa or a lambda light chain.
POROS CaptureSelect IgG-Fc; for the detection of any human IgG subclass (even IgG3) in the presence of IgG from other sources (e.g bovine).
POROS CaptureSelect IgM; for the analysis of human, mouse and rat IgM.
POROS CaptureSelect HSA; for the analysis of HSA-fusion proteins (specific for human serum albumin in the presence of albumin from other species).
Christine Gebski, head of Life Technologies POROS business said: 'We believe the addition of these products to our existing Affinity Chromatography Column line will unlock the same benefits of rapid, automatable quantitation or small scale purification for many other classes of biological molecules.'
